MX9700152A - Nueva formulacion farmaceutica oral, que contiene sal de magnesio de omeprazol. - Google Patents

Nueva formulacion farmaceutica oral, que contiene sal de magnesio de omeprazol.

Info

Publication number
MX9700152A
MX9700152A MX9700152A MX9700152A MX9700152A MX 9700152 A MX9700152 A MX 9700152A MX 9700152 A MX9700152 A MX 9700152A MX 9700152 A MX9700152 A MX 9700152A MX 9700152 A MX9700152 A MX 9700152A
Authority
MX
Mexico
Prior art keywords
omeprazole
magnesium salt
oral pharmaceutical
pharmaceutical formulation
formulation containing
Prior art date
Application number
MX9700152A
Other languages
English (en)
Spanish (es)
Inventor
Siv Inga Bengtsson
Kurt Ingmar Lovgren
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of MX9700152A publication Critical patent/MX9700152A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
MX9700152A 1994-07-08 1995-07-03 Nueva formulacion farmaceutica oral, que contiene sal de magnesio de omeprazol. MX9700152A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9400679 1994-07-08
PCT/SE1995/000816 WO1996001622A1 (en) 1994-07-08 1995-07-03 New oral pharmaceutical formulation containing magnesium salt of omeprazole

Publications (1)

Publication Number Publication Date
MX9700152A true MX9700152A (es) 1997-04-30

Family

ID=20393105

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9700152A MX9700152A (es) 1994-07-08 1995-07-03 Nueva formulacion farmaceutica oral, que contiene sal de magnesio de omeprazol.

Country Status (15)

Country Link
EP (1) EP0768872A1 (fi)
KR (1) KR970704426A (fi)
BR (1) BR9508261A (fi)
CA (1) CA2193681A1 (fi)
CZ (1) CZ379596A3 (fi)
EE (1) EE03378B1 (fi)
FI (1) FI970058A (fi)
HU (1) HUT78132A (fi)
IS (1) IS4398A (fi)
MX (1) MX9700152A (fi)
NO (1) NO970036D0 (fi)
NZ (1) NZ289958A (fi)
PL (1) PL181265B1 (fi)
SK (1) SK166096A3 (fi)
WO (1) WO1996001622A1 (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US5900258A (en) * 1996-02-01 1999-05-04 Zeolitics Inc. Anti-bacterial compositions
SI9700186B (sl) 1997-07-14 2006-10-31 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6096340A (en) 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
SE9704870D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6316020B1 (en) * 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
AU3762801A (en) * 2000-03-09 2001-09-17 Andrew Ilchyshyn Treatment of inflammatory dermatoses comprising erythromycin or clarythromycin metronidazole and a gastrointestinal hydrogen pump inhibitor
EP1133987A1 (en) * 2000-03-09 2001-09-19 Ian Whitcroft Treatment of inflammatory dermatoses with combinations of erythromycin or clarythromycin, metronidazole and a hydrogen pump inhibitor
CA2771725C (en) 2002-10-16 2015-08-18 Takeda Pharmaceutical Company Limited Solid preparation comprising a non-toxic base and a proton pump inhibitor
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1755566A2 (en) * 2004-06-15 2007-02-28 Teva Pharmaceutical Industries Ltd Stable pharmaceutical formulations of benzimidazole compounds
CN105106168B (zh) * 2015-08-19 2018-03-06 德州德药制药有限公司 一种埃索美拉唑镁肠胶囊及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
JPH0768125B2 (ja) * 1988-05-18 1995-07-26 エーザイ株式会社 酸不安定化合物の内服用製剤
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation

Also Published As

Publication number Publication date
SK166096A3 (en) 1997-09-10
AU695723B2 (en) 1998-08-20
IS4398A (is) 1996-12-17
EE03378B1 (et) 2001-04-16
NZ289958A (en) 1998-09-24
NO970036L (no) 1997-01-06
KR970704426A (ko) 1997-09-06
NO970036D0 (no) 1997-01-06
EE9700014A (et) 1997-06-16
WO1996001622A1 (en) 1996-01-25
HUT78132A (hu) 2000-06-28
FI970058A0 (fi) 1997-01-07
WO1996001622A8 (en) 1999-12-23
CZ379596A3 (en) 1997-08-13
EP0768872A1 (en) 1997-04-23
HU9700039D0 (en) 1997-02-28
FI970058A (fi) 1997-01-07
BR9508261A (pt) 1997-12-23
CA2193681A1 (en) 1996-01-25
AU2994795A (en) 1996-02-09
PL181265B1 (pl) 2001-06-29
PL318464A1 (en) 1997-06-09

Similar Documents

Publication Publication Date Title
MX9700152A (es) Nueva formulacion farmaceutica oral, que contiene sal de magnesio de omeprazol.
MY128809A (en) Pharmaceutical formulation of omeprazole
EP1078628A3 (en) Multiple unit tableted dosage form
GEP20033014B (en) Enteric Coated Pharmaceutical Composition and Method of Manufacturing
MX9604354A (es) Nueva forma de dosis farmaceutica oral.
EP1123087A4 (en) ORAL SYSTEM FOR THE ADMINISTRATION OF PULSED DOSES OF A MEDICAMENT
HK1031197A1 (en) Osmotic dosage form comprising first and second coats
PL341055A1 (en) Novel form of a drug for oral administration of active compounds being unstable in acid environments
AR243375A1 (es) Preparacion farmaceutica, capsula de gelatina con revestimiento enterico. procedimiento y aparato.
WO2003039632A3 (en) A medicament container, a medicament dispensing kit for administering medication and a method for packaging the same
WO2000018447A3 (en) Multiplex drug delivery system suitable for oral administration
ZA9610852B (en) Peelable heat-sealable multilayer polyolefin film process for the production thereof and the use thereof
GR3005399T3 (fi)
NO934836D0 (no) Fremgangsmaate for fremstilling og anvendelse som medikament eller diagnostikum av 2,4-substituerte 5-(N-substituerte-sulfamoyl)-benzoylgu anidiner, og medikamenter som inneholder disse
DE69401972D1 (de) Feste Arzneimitteldosierungsform und Methode zur Verminderung des Abriebs
IS4030A (is) Lyf, ætlað til inntöku, sem hefur bakteríueyðandiáhrif í maga, aðferð við framleiðslu þess og notkun
NO975634L (no) Stabile farmasöytiske preparater inneholdende tiludronathydrater og fremgangsmåte for fremstilling av farmasöytiske preparater
NZ226482A (en) Coated tablet formulation comprising separate decongestant and antihistamine coating or zones
NO306993B1 (no) Piperidinylmetyloksyzolidin-2-on-derivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler
JO1821B1 (en) New pharmaceutical product
EP0679391A3 (en) Solid pharmaceutical forms with a flavored coating.
EE9600050A (et) Meetod kinoloone sisaldavate oraalsete kompositsioonide valmistamiseks ja tablett kinoloonide oraalseks manustamiseks
IT238786Y1 (it) Contenitore distributore, specialmente per prodotti medicianali in compresse o capsule e simili.
IT1280082B1 (it) Imballo per bottiglie o simili, per impilaggio autoportante ed autovincolante
FI961956A0 (fi) Medicinfoerpackning som moejliggoer utmaerkning av tidpunkten foer medicintagning